selected publications
-
Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia.
Haematologica.
2018
Academic Article
GET IT
Times cited: 32 -
Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia.
Leukemia & lymphoma.
2017
Letter
GET IT
Times cited: 12 -
Minimal residual disease in acute myelogenous leukemia.
International journal of laboratory hematology.
2017
Information Resource
GET IT
Times cited: 41 -
Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells.
Blood cells, molecules & diseases.
2013
Academic Article
GET IT
Times cited: 58 -
A TAP1 null mutation leads to an enlarged olfactory bulb and supernumerary, ectopic olfactory glomeruli.
Open biology.
2013
Academic Article
GET IT
Times cited: 1